Diabetes
Conference Coverage
ESC backs SGLT2 inhibitor plus GLP-1 in diabetes with high CVD risk
Another major change in the new ESC guideline revision is introduction of a CVD risk calculator intended to estimate the risk among people with...
From the Journals
Artificial sweeteners no help for weight loss: Review
An updated review of the leading scientific evidence on artificial sweeteners suggests that far from positively affecting our health, they have “...
From the Journals
Simple blood test may predict heart and kidney risk in T2D
“Three out of the four biomarkers are already clinically and commercially available,” while the fourth, for insulin-like growth factor binding...
Opinion
American Geriatrics Society 2023 updated Beers Criteria highlights
The guidelines address safe prescribing of medications to older adults after review of 1,500 clinical trials and research studies.
Latest News
‘Water fasting’ benefits don’t last
Five days of water fasting lowered weight by about 6%, but this weight was regained after 3 months of regular eating.
From the Journals
Statins post PCI: Moderate intensity plus ezetimibe may be preferable
“If given the choice, if you can get the benefits from a cardiovascular perspective with a lower risk of diabetes, it makes sense to use the...
From the Journals
Vegetarian diets can improve high-risk cardiovascular disease
“This meta-analysis is the first that generates evidence from randomized controlled trials to assess the association of vegetarian diets with...
Latest News
Experts call for early screening for chronic kidney disease
Nearly all patients seen in primary care are candidates for screening because of their risk factors for kidney disease, such as diabetes and...
Latest News
Weighing childhood obesity interventions
The long-term effects of these new agents on children and teens are poorly understood, and both medication and surgery are associated with...
Conference Coverage
OASIS and PIONEER PLUS support high-dose oral semaglutide
OASIS-1 showed that “oral semaglutide 50 mg may represent an effective option for the treatment of obesity, particularly in patients who prefer...
Conference Coverage
‘Striking’ benefit of lipid lowering in primary prevention
“If patients can’t tolerate a statin, then treat them with bempedoic acid. The bottom line is that these patients just need to be treated.”